LONDON--(BUSINESS WIRE)--Technavio has announced the top five leading vendors in their recent global botulinum toxin market report. This research report also lists 23 other prominent vendors that are expected to impact the market during the forecast period.
Botulinum toxin, also known as BOTOX therapy, was originally used to treat dystonia. Dystonia is a neuromuscular disorder that produces involuntary muscle contractions or spasms. These undesired muscle movements mainly affect movement in the eyes, limbs, neck, face, voice box, or the smooth muscle in the bladder. The goal of the therapy is to reduce muscle spasm and pain.
Competitive vendor landscape
The development of drugs for the treatment of growing spasticity disorders such as wrinkles will increase the competition among vendors. ALLERGAN, Ipsen, and Merz Pharma are dominating the market. However, ALLERGAN and Ipsen have the first-mover advantage in the aesthetic drugs market.
“The growing focus of vendors in the aesthetic market will change the market dynamics. For example, in March 2016, Merz Pharma received the EC approval for Bocouture for the treatment of upper facial lines,” says Sapna Jha, a lead infectious and rare diseases research analyst from Technavio.
Looking for more information on this market? Request a free sample report
Technavio’s sample reports are free of charge and contain multiple sections of the report including the market size and forecast, drivers, challenges, trends, and more.
Top five botulinum toxin market vendors
ALLERGAN
ALLERGAN undertakes the discovery, development, and commercialization of pharmaceuticals, biologics, medical devices, and over the counter (OTC) products. The company also operates in the areas such as ophthalmology, neurosciences and medical aesthetics/dermatology/plastic surgery, central nervous system, gastroenterology, women’s health, and urology.
Galderma
Galderma facilitates therapeutic and aesthetic solutions for the treatment of individuals with skin diseases. The company focuses on the R&D, manufacturing, and marketing of a wide range of drugs, pharmaceuticals, and biosimilars, mainly for the dermatology therapeutic area. The company has a strong operational presence with five R&D centers (France, Sweden, Switzerland, the US, and Japan), six manufacturing sites (France, Canada, Sweden, Switzerland, Germany, and Brazil), and 35 affiliates.
Ipsen
Ipsen is a specialty-driven pharmaceutical group that focuses on the discovery and development of new solutions for the treatment of various conditions such as pain. The company leverages on its key muscle relaxant drug, Dysport.
Merz Pharma
Merz Pharma engages in the R&D and distribution of various products in the areas of aesthetic medicine and neurological disorders. It specializes in providing products in different therapeutic areas, including hair loss, medical dermatology, Alzheimer’s disease, liver disease, and Parkinson’s disease. It also offers health, wellness, beauty, and healthcare bath products. The company's products are used by healthcare professionals in over 90 countries.
Pfizer
Pfizer is a research-based biopharmaceutical company that produces, manufactures, and develops a wide range of pharmaceutical products for various therapy areas including arthritis, cardiovascular diseases, metabolic disorders, infections, and respiratory disorders.
Browse Related Reports:
- Global Orphan Drugs Market 2017-2021
- Global Bovine Respiratory Disease Treatment 2017-2021
- Global Animal Parasiticides Market 2017-2021
Become a Technavio Insights member and access all three of these reports for a fraction of their original cost. As a Technavio Insights member, you will have immediate access to new reports as they’re published in addition to all 6,000+ existing reports covering segments like medical imaging, oncology, and vaccines. This subscription nets you thousands in savings, while staying connected to Technavio’s constant transforming research library, helping you make informed business decisions more efficiently.
About Technavio
Technavio is a leading global technology research and advisory company. The company develops over 2000 pieces of research every year, covering more than 500 technologies across 80 countries. Technavio has about 300 analysts globally who specialize in customized consulting and business research assignments across the latest leading edge technologies.
Technavio analysts employ primary as well as secondary research techniques to ascertain the size and vendor landscape in a range of markets. Analysts obtain information using a combination of bottom-up and top-down approaches, besides using in-house market modeling tools and proprietary databases. They corroborate this data with the data obtained from various market participants and stakeholders across the value chain, including vendors, service providers, distributors, re-sellers, and end-users.
If you are interested in more information, please contact our media team at media@technavio.com.
